[1] |
Weinstein EJ, Head R, Griggs DW, et al. VCC-1, a novel chemokine, promotes tumor growth[J]. Biochem Biophys Res Commun, 2006, 350(1): 74-81.
|
[2] |
Pisabarro MT, Leung B, Kwong M, et al. Cutting edge: novel human dendritic cell-and monocyte-attracting chemokine-like protein identified by fold recognition methods [J]. J Immunol, 2006, 176(4): 2069-2073.
|
[3] |
Zlotnik A, Yoshie O. The chemokine superfamily revisited[J]. Immunity, 2012, 36(5): 705-716.
|
[4] |
Maravillas-Montero JL, Burkhardt AM, Hevezi PA, et al. Cutting edge: GPR35/CXCR8 is the receptor of the mucosal chemokine CXCL17[J]. J Immunol, 2015, 194(1): 29-33.
|
[5] |
刘振生, 赵红川, 黄帆, 等. VCC-1在肝癌患者血、尿和癌组织中的表达及其意义[J]. 肝胆外科杂志, 2014, 22(6): 471-473.
|
[6] |
Burkhardt AM, Tai KP, Flores-Guiterrez JP, et al. CXCL17 is a mucosal chemokine elevated in idiopathic pulmonary fibrosis that exhibits broad antimicrobial activity[J]. J Immunol, 2012, 188(12): 6399-6406.
|
[7] |
Hernández-Ruiz M, Zlotnik A. Mucosal chemokines[J]. J Interferon Cytokine Res, 2017, 37(2): 62-70.
|
[8] |
Zhou Z, Lu X, Zhu P, et al. VCC-1 over-expression inhibits cisplatin-induced apoptosis in HepG2 cells[J]. Biochem Biophys Res Commun, 2012, 420(2): 336-342.
|
[9] |
牟霞, 陈瑶, 王穗海, 等. VCC-1真核表达载体的构建及肝癌细胞SMMC7721稳定转染株的建立及鉴定[J]. 细胞与分子免疫学杂志, 2009, 25(1): 79-81.
|
[10] |
Lee WY, Wang CJ, Lin TY, et al. CXCL17, an orphan chemokine, acts as a novel angiogenic and anti-inflammatory factor[J]. Am J Physiol Endocrinol Metab, 2013, 304(1): E32-40.
|
[11] |
刘祖平, 杨成万. CXCL17在肿瘤中表达意义及功能的研究进展[J]. 西南医科大学学报, 2018, 41(5): 462-466.
|
[12] |
韩兴涛, 杨凌博, 魏澎涛, 等. miR-210-3p通过靶向ATG7抑制人膀胱癌细胞J82的自噬和诱导凋亡[J]. 中国临床解剖学杂志, 2018, 36(6): 615-620.
|
[13] |
Lorin S, Hamaï A, Mehrpour M, et al. Autophagy regulation and its role in cancer [J]. Semin Cancer Biol, 2013, 23(5): 361-379.
|
[14] |
胡晓芳, 邱仁杰, 余磊, 等. 纳米载体SWCNT投递Bcl-2 siRNA促进U251细胞凋亡[J]. 中国临床解剖学杂志, 2017, 35(05): 521-525.
|